This MRI Contrast Agent May Cause Serious Side Effects. Have You Been Effected?
Gadolinium is used in the contrasts dyes that are injected into patients before having magnetic resonance imaging (MRI) or magnetic resonance angiography (MRA) procedures. As of 2015, gadolinium-based contrast agents had been used in more than 100 million patients worldwide. Recent studies show that gadolinium does not totally leave the body after an MRI or MRA. It has been shown to accumulate in the brain and other parts of the body, leading to serious health problems. If you are experiencing health issues related to gadolinium, you may have a claim.
Gadolinium May Build to Toxic Levels in the Body
Gadolinium is a rare-earth metallic element with magnetic properties. These magnetic properties make it useful in the medical field, mostly for use in MRI and MRA scans. In an FDA Safety Alert published December 19, 2017, the FDA will now require a new class warning and other safety measures for these contrast agents. Their concern is “gadolinium remaining in patients’ bodies, including the brain, for months to years after receiving these drugs.” This buildup in the body can lead to Gadolinium Storage Condition, Gadolinium Deposition Disease, and Nephrogenic Systemic Fibrosis.
Gadolinium Storage Condition versus Gadolinium Deposition Disease – What’s the Difference?
Gadolinium Storage Condition occurs when a person with normal kidney function has excess gadolinium in their body. A person with this condition may not have noticeable symptoms.
In people with Gadolinium Deposition Disease, symptoms can appear from a few hours to several weeks after they are injected with the contrast agent containing gadolinium. There are a variety of side effects associated with this condition and symptoms can persist for weeks, months or years.
Gadolinium Deposition Disease (GDD) Symptoms
Symptoms of GDD may include:
- Bone and joint pain
- Brain fog or “chemo brain” symptoms
- Burning and itching sensations
- Persistent headache
- Skin hardening, thickening or tightening
Nephrogenic Systemic Fibrosis (NSF) Symptoms
Nephrogenic Systemic Fibrosis occurs mainly in people suffering from kidney disease or failure. For those suffering with kidney problems, exposure to gadolinium-based contrast agents used during imaging scans has been identified as a trigger for developing this disease. NSF may also affect internal organs, such as heart, kidneys and lungs. Symptoms of NSF may include:
- Swelling and tightening of the skin
- Thickening and hardening of the skin
- Skin with orange-peel appearance and darkening (excess pigmentation)
- Burning, itching or pain in effected areas
- Skin thickening that inhibits movement, resulting in loss of joint flexibility
Have Any Gadolinium Deposition Disease Lawsuits Been Filed?
Gadolinium-related NSF lawsuits caught the public attention as early as 2005. On November 2, 2017, a gadolinium lawsuit again made big news. Actor Chuck Norris and his wife Gena filed suit in California alleging that the chemical used in MRI imaging scans (gadolinium) poisoned Mrs. Norris. The lawsuit alleges that manufacturers of the contrast agents knew of the risks that gadolinium posed but failed to warn consumers.
The Attorneys of Davis & Crump Will Help You
If you or someone you love are suffering from gadolinium-related injuries, our experienced team at Davis & Crump is here to help. Our attorneys and support staff are dedicated to protecting your rights and interests throughout the litigation process.
Contact the Gadolinium Contrast attorneys at Davis & Crump today. There is no risk to you and there are no fees unless we win for you.
Fill out a free claim evaluation or call us at 1-800-277-0300 to get started.